Back to search
Meningoccocal Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Meningoccocal Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Meningoccocal Disease trials you may qualify forThis study will measure immune persistence of the NmCV-5 more than 5 years after a single dose vaccination in participants 2-29 years of age in Mali and The Gam…
The aim of this extension study is to explore the antibody persistence 24 to 36 months after the last dose of vaccine, in infants that received a two or three d…